Robert Carey Insider Trading $HZNP Horizon Therapeutics Public Ltd Co

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Robert Carey.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Robert Carey. Robert Carey is Director in SANGAMO BIOSCIENCES INC ($SGMO) and Director in ARGOS THERAPEUTICS INC ($ARGS) and EVP & Chief Business Officer in Horizon Pharma plc ($HZNP) and EVP, Chief Business Officer in Horizon Pharma plc ($HZNP) and Director in AIT Therapeutics, Inc. ($AITB).

Robert Carey in Horizon Therapeutics Public Ltd Co

Trading Symbol: HZNP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert Carey: EVP, Chief Business Officer, EVP & Chief Business Officer
Holdings: 31,000 shares
Current Value: $522,660
Latest Transaction: Mar 25 2019
$HZNP Market Capitalization: $2.68B
$HZNP Previous Close: $16.86

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Robert Carey in Horizon Therapeutics Public Ltd Co

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ARGS, AITB, HZNP, SGMO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 25 2019HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Option ExerciseM0.0031,00000
Mar 25 2019HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Option ExerciseM0.0031,00000
Mar 25 2019HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Payment of ExerciseF26.8413,733368,59417,26731 K to 17.3 K (-44.30 %)
Mar 25 2019HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Payment of ExerciseF26.8413,733368,59417,26731 K to 17.3 K (-44.30 %)
Mar 25 2019HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...BuyM0.0031,000031,0000 to 31 K
Mar 25 2019HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...BuyM0.0031,000031,0000 to 31 K
Feb 22 2019HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Payment of ExerciseF21.5432,064690,65940,31172.4 K to 40.3 K (-44.30 %)
Feb 22 2019HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...GrantA0.0072,375072,3750 to 72.4 K
Jan 08 2019HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Option ExerciseM0.0065,6950131,392
Jan 08 2019HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Option ExerciseM0.0065,6950131,392
Jan 08 2019HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Option ExerciseA0.0053,948053,948
Jan 08 2019HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Option ExerciseA0.0053,948053,948
Jan 08 2019HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Payment of ExerciseF20.3929,419599,85336,27665.7 K to 36.3 K (-44.78 %)
Jan 08 2019HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Payment of ExerciseF20.3929,419599,85336,27665.7 K to 36.3 K (-44.78 %)
Jan 08 2019HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...BuyM0.0065,695065,6950 to 65.7 K
Jan 08 2019HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...BuyM0.0065,695065,6950 to 65.7 K
May 07 2018HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Option ExerciseA0.00197,0870197,087
May 07 2018HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Option ExerciseA0.00197,0870197,087
Mar 27 2018HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Option ExerciseM0.0031,000031,000
Mar 27 2018HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Payment of ExerciseF13.869,083125,89039,10648.2 K to 39.1 K (-18.85 %)
Mar 27 2018HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...BuyM0.0031,000048,18917.2 K to 48.2 K (+180.35 %)
Mar 07 2018HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Option ExerciseM0.0031,02500
Mar 07 2018HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Payment of ExerciseF15.8313,836219,02417,18931 K to 17.2 K (-44.60 %)
Mar 07 2018HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...BuyM0.0031,025031,0250 to 31 K
Mar 24 2017HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Option ExerciseM0.0031,000062,000
Mar 24 2017HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Payment of ExerciseF14.5614,167206,27234,19048.4 K to 34.2 K (-29.30 %)
Mar 24 2017HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...BuyM0.0031,000048,35717.4 K to 48.4 K (+178.60 %)
Mar 07 2017HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Option ExerciseM0.0031,025031,025
Mar 07 2017HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Payment of ExerciseF16.1114,268229,85717,35731.6 K to 17.4 K (-45.12 %)
Mar 07 2017HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...BuyM0.0031,025031,625600 to 31.6 K (+5,170.83 %)
Mar 02 2017HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Option ExerciseX4.316,91329,7810
Mar 02 2017HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...SellS16.0030,000480,00095,408125.4 K to 95.4 K (-23.92 %)
Mar 02 2017HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...SellS16.481,80829,796125,408127.2 K to 125.4 K (-1.42 %)
Mar 02 2017HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...BuyX4.316,91329,781127,216120.3 K to 127.2 K (+5.75 %)
Mar 24 2016HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Option ExerciseM0.0031,000093,000
Mar 24 2016HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Payment of ExerciseF16.3214,167231,20538,24252.4 K to 38.2 K (-27.03 %)
Mar 24 2016HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...BuyM0.0031,000052,40921.4 K to 52.4 K (+144.80 %)
Mar 07 2016HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Option ExerciseM0.0031,025062,050
Mar 07 2016HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Payment of ExerciseF16.789,616161,35621,40931 K to 21.4 K (-30.99 %)
Mar 07 2016HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...BuyM0.0031,025031,0250 to 31 K
Mar 07 2016HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...GiftG0.0024,406082,06157.7 K to 82.1 K (+42.33 %)
Mar 07 2016HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...GiftG0.0024,4060024.4 K to 0 (-100.00 %)
May 08 2015HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Option ExerciseA0.00699,0000699,000
Mar 25 2015HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Option ExerciseA0.00233,0000233,000
Mar 25 2015HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Option ExerciseA0.00124,0000124,000
Mar 25 2015HZNPHorizon Pharma plcCarey RobertEVP, Chief Business ...Option ExerciseA22.14276,0006,110,640276,000
Mar 09 2015HZNPHorizon Pharma plcCarey RobertEVP & Chief Busines ...Option ExerciseM0.0031,025093,075
Mar 09 2015HZNPHorizon Pharma plcCarey RobertEVP & Chief Busines ...Payment of ExerciseF20.849,736202,89823,24533 K to 23.2 K (-29.52 %)
Mar 09 2015HZNPHorizon Pharma plcCarey RobertEVP & Chief Busines ...BuyM0.0031,025032,9812 K to 33 K (+1,586.15 %)
Mar 07 2014HZNPHorizon Pharma plcCarey RobertEVP & Chief Busines ...Option ExerciseA0.00124,1000124,100
Mar 07 2014HZNPHorizon Pharma plcCarey RobertEVP & Chief Busines ...Option ExerciseA13.34100,0001,334,000100,000
Mar 07 2014HZNPHorizon Pharma plcCarey RobertEVP & Chief Busines ...Option ExerciseA13.34140,0001,867,600140,000

Page:   1

Contact us | Follow us on Twitter